The U.S. Copyright Office is currently in the process of conducting its 6th triennial rulemaking review under 17 U.S.C. § 1201 of the Digital Millennium
Originating back in 2006, the litigation between Pfizer and Apotex over Pfizer’s blockbuster drug, Lipitor, has been long and arduous. With many twists and turns